Investing in tomorrow's healthcare

Investment

Angels in MedCity alumnus Sense Biodetection has raised £12.3M to develop a portfolio of instrument-free, point-of-care molecular diagnostic tests.

CamBioScience Ltd has secured c.£1.1m of funding led by an early stage investment house, Beaubridge (UK) Ltd

Jupiter Diagnostics raises £1.6m investment, supported by Angels in MedCity

Jupiter Diagnostics Logo

Angels in MedCity has supported London scale-up Jupiter Diagnostics to raise £1.6m to develop its reader, allowing anyone to perform quick, affordable blood tests. The company raised the investment, which included participation from the LBA EIS Roundtable Syndicate Fund 2016 and the London Co-Investment Fund (LCIF), to develop its product and expand into other markets across Europe.  

Angels in MedCity supports Eagle Genomics to raise £1m investment

Cambridge-based bioinformatics specialist, Eagle Genomics, has been supported to raise £1m in investment through the Angels in MedCity programme; a partnership between MedCity, LBA and Angels4LifeSciences.

The investment, which included participation from the LBA EIS Roundtable Syndicate Fund 2016 and the London Co-Investment Fund (LCIF), will help Eagle Genomics to develop technology that will reduce research costs and time, and help companies get their products to market faster.

Become an Angels in MedCity investor

Become an investor >

 

Become an Angels in MedCity entrepreneur

Entrepreneurs >

 

On Twitter

@OxfordHeartbeat is developing a software for stent fitting simulation in 3D #aimc19 @MedCityHQ https://t.co/gS78hoDlxH
4 days 6 hours ago
@SurePulseMed is developing technologies to monitor vital signs in newborn babies #aimc19 @MedCityHQ https://t.co/xHxxyr9NXo
4 days 7 hours ago